Literature DB >> 17401072

Disease monitoring of patients with chronic heart failure.

M Gary Nicholls1, A Mark Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17401072      PMCID： PMC1861485          DOI： 10.1136/hrt.2005.078519

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

1.  Preventable causative factors leading to hospital admission with decompensated heart failure.

Authors:  A Michalsen; G König; W Thimme
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

2.  Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

Authors:  D R Murdoch; T A McDonagh; J Byrne; L Blue; R Farmer; J J Morton; H J Dargie
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

3.  Relationship between accurate auscultation of a clinically useful third heart sound and level of experience.

Authors:  Gregory M Marcus; Gregory Marcus; Joshua Vessey; Mark V Jordan; Michele Huddleston; Barry McKeown; Ivor L Gerber; Elyse Foster; Kanu Chatterjee; Charles E McCulloch; Andrew D Michaels
Journal:  Arch Intern Med       Date:  2006-03-27

4.  Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

Authors:  G C Fonarow; L W Stevenson; J A Walden; N A Livingston; A E Steimle; M A Hamilton; J Moriguchi; J H Tillisch; M A Woo
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

5.  Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.

Authors:  N Suskin; T Sheth; A Negassa; S Yusuf
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

6.  Acute precipitants of congestive heart failure exacerbations.

Authors:  R T Tsuyuki; R S McKelvie; J M Arnold; A C Barretto; A C Carvalho; D L Isaac; A D Kitching; L S Piegas; K K Teo; S Yusuf
Journal:  Arch Intern Med       Date:  2001-10-22

7.  Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.

Authors:  S M Butman; G A Ewy; J R Standen; K B Kern; E Hahn
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

8.  Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.

Authors:  Jeffrey W H Fung; Cheuk M Yu; Gabriel Yip; Skiva Chan; Timothy G Yandle; A Mark Richards; M Gary Nicholls; John E Sanderson
Journal:  Am J Cardiol       Date:  2003-08-15       Impact factor: 2.778

9.  Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure.

Authors:  Andrzej Gackowski; Richard Isnard; Jean-Louis Golmard; Françoise Pousset; Alain Carayon; Gilles Montalescot; Jean-Sébastien Hulot; Daniel Thomas; Wieslawa Piwowarska; Michel Komajda
Journal:  Eur Heart J       Date:  2004-10       Impact factor: 29.983

10.  Heritability and genetic linkage of plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Diane Corey; Eric P Leip; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.